About Summa Health System Hospitals
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Summa Health System Hospitals
During the past decade, Summa Health System Hospitals conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
2008-07-01
2009-10-01
Completed
405
Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
2009-02-12
2011-01-12
Terminated
2,720
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins
2011-06-01
2012-06-01
Completed
46
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.
2011-07-01
2013-10-01
Completed
922
Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
2011-11-01
2013-01-01
Completed
345
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Summa Health System Hospitals"
#1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Summa Health System Hospitals
According to Clinical.Site data, the most researched conditions in "Summa Health System Hospitals" are
"Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Complicated Urinary Tract Infection" (1 trials). Many other conditions were trialed in "Summa Health System Hospitals" in a lesser frequency.
Clinical Trials Intervention Types at Summa Health System Hospitals
Most popular intervention types in "Summa Health System Hospitals" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Imipenem/Cilastatin" (1 trials), "NXL104/ceftazidime" (1 trials), "Neratinib" (1 trials), "Nipent, Cytoxan, Rituxan" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Summa Health System Hospitals
The vast majority of trials in "Summa Health System Hospitals" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Summa Health System Hospitals
Currently, there are NaN active trials in "Summa Health System Hospitals".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Summa Health System Hospitals,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Summa Health System Hospitals, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".